- Home
- ANEB vs FATE Comparison
ANEB vs FATE Comparison
Compare ANEB & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FATE
- Stock Information
- Founded
- ANEB 2020
- FATE 2007
- Country
- ANEB United States
- FATE United States
- Employees
- ANEB N/A
- FATE N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANEB Health Care
- FATE Health Care
- Exchange
- ANEB Nasdaq
- FATE Nasdaq
- Market Cap
- ANEB 111.8M
- FATE 116.5M
- IPO Year
- ANEB 2021
- FATE 2013
- Fundamental
- Price
- ANEB $2.76
- FATE $1.85
- Analyst Decision
- ANEB Buy
- FATE Hold
- Analyst Count
- ANEB 2
- FATE 6
- Target Price
- ANEB $8.00
- FATE $3.30
- AVG Volume (30 Days)
- ANEB 25.7K
- FATE 3.2M
- Earning Date
- ANEB 11-12-2025
- FATE 11-11-2025
- Dividend Yield
- ANEB N/A
- FATE N/A
- EPS Growth
- ANEB N/A
- FATE N/A
- EPS
- ANEB N/A
- FATE N/A
- Revenue
- ANEB N/A
- FATE $8,470,000.00
- Revenue This Year
- ANEB N/A
- FATE N/A
- Revenue Next Year
- ANEB N/A
- FATE N/A
- P/E Ratio
- ANEB N/A
- FATE N/A
- Revenue Growth
- ANEB N/A
- FATE N/A
- 52 Week Low
- ANEB $0.80
- FATE $0.66
- 52 Week High
- ANEB $3.42
- FATE $3.50
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- FATE 72.17
- Support Level
- ANEB $2.50
- FATE $1.42
- Resistance Level
- ANEB $2.76
- FATE $1.58
- Average True Range (ATR)
- ANEB 0.12
- FATE 0.15
- MACD
- ANEB 0.03
- FATE 0.01
- Stochastic Oscillator
- ANEB 85.00
- FATE 100.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.